Results 11 to 20 of about 1,399,448 (251)

Antiplatelet agents and proton pump inhibitors – personalizing treatment

Pharmacogenomics and Personalized Medicine, 2010
Eugene Lin, Rajiv Padmanabhan, Majaz MoonisDepartment of Neurology, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USAIntroduction: Antiplatelet therapy remains one of the cornerstones in the ...
Eugene Lin, Rajiv Padmanabhan, Majaz Moonis   +2 more
doaj   +1 more source

Proton pump inhibitors and hypomagnesemia monitoring

International Journal of General Medicine, 2013
Thomas I LemonInstitute of Medical Education, Cardiff University School of Medicine, Cardiff, UKI thank El-Charabaty et al1 for their interesting paper which concludes that patients in receipt of proton pump inhibitors (PPIs) need to be followed closely ...
Lemon TI
doaj   +2 more sources

ENDOSCOPIC AND HISTOPATHOLOGIC GASTRIC CHANGES IN CHRONIC USERS OF PROTON-PUMP INHIBITORS [PDF]

Arquivos de Gastroenterologia, 2015
Background Proton-pump inhibitors have been used for at least two decades. They are among the most commonly sold drugs in the world. However, some controversy remains about the indications for their use and the consequences of their prolonged use ...
Sílvia Maria Perrone CAMILO, Élia Cláudia de Souza ALMEIDA, Benito André Silveira MIRANZI, Juliano Carvalho SILVA, Rosemary Simões NOMELINI, Renata Margarida ETCHEBEHERE   +5 more
doaj   +2 more sources

Research of the assortment of the proton pump inhibitors on the regional drugs market

RUDN Journal of Medicine, 2013
Proton pump inhibitors are new most effective remedies for the treatment of gastric ulcer and duodenal ulcer. Analysis results of proton pump inhibitors assortment on the regional market are presented in the article.
O G Ivchenko, E A Popova, N A Andreeva, S A Mikhailova, L A Zolotukhina   +4 more
doaj   +1 more source

Proton Pump Inhibitors: How Safe is Long Usage of Pantoprazole?

Gastroenterologìa, 2013
The article deals with the approaches to treatment of acid-related diseases, there was determined key role of proton pump inhibitors. The special attention was given to safety of long usage of proton pump inhibitors, there were analyzed the findings of ...
Yu.M. Stepanov, I.Ya. Budzak
doaj   +2 more sources

Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors

Gastroenterologìa, 2014
Article deals with the use of proton pump inhibitors in gastroenterology. We considered the impact of proton pump inhibitors on of a variety of processes in the body, such as the absorption of vitamins and minerals, osteoporosis and fractures, the risks ...
S.M. Tkach
doaj   +2 more sources

Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. [PDF]

, 2012
Introduction Emerging epidemiological evidence suggests that proton pump inhibitor (PPI) acid-suppression therapy is associated with an increased risk of Clostridium difficile infection (CDI).
Sutton, AJ, Imad M. Tleyjeh (104252), Tannir Mohamad Al, Alex J Sutton, AlGhamdi, M, Muhammad Riaz (104236), Bin Abdulhak, AA, Ibrahim Talal, Mushabab AlGhamdi (112556), Baddour, LM, Alasmari Faisal A., A. A. Bin Abdulhak (7656569), Abed Allehibi, Talal Ibrahim (112568), Allehibi, A., Alasmari, FA, Faisal A. Alasmari (112549), F. A. Alasmari (7656575), A. R. Khan (3951662), AlGhamdi Mushabab, A. AlLehibi (7656593), Khan, AR, Al Tannir, M, Tleyjeh, IM, I. M. Tleyjeh (7656566), AlGhamdi, M., Abed AlLehibi (112573), Khan, A. R., Alex J. Sutton (112577), Garbati Musa A., L. M. Baddour (7656596), Aref A Bin Abdulhak, M. A. Garbati (7656578), M. Al Tannir (7656584), Bin Abdulhak, A. A., M. AlGhamdi (7656581), Erwin, P. J., Imad M Tleyjeh, Khan Abdur Rahman, Tleyjeh, I. M., Patricia J Erwin, T. Ibrahim (7656590), Muhammad Riaz, Abdur Rahman Khan (104234), Garbati, MA, Allehibi, A, Bin Abdulhak Aref A., Erwin, PJ, Sutton Alex J., M. Riaz (7656572), Riaz Muhammad, Musa A Garbati, Alasmari, F. A., Patricia J. Erwin (104246), Talal Ibrahim, Abdur Rahman Khan, Ibrahim, T., Mushabab AlGhamdi, A. J. Sutton (7648487), Faisal A Alasmari, Ibrahim, T, Mohamad Al Tannir (112562), Mohamad Al Tannir, Erwin Patricia J., Larry M Baddour, Baddour Larry M., Al Tannir, M., P. J. Erwin (7656587), Aref A. Bin Abdulhak (104239), Garbati, M. A., Larry M. Baddour (104249), Riaz, Muhammad, Riaz, M, Tleyjeh Imad M., Baddour, L. M., Sutton, A. J., Musa A. Garbati (104244), AlLehibi Abed   +77 more
core   +1 more source

Proton-pump inhibitors

South African Family Practice, 2015
Proton-pump inhibitors (PPIs) are a class of drugs that profoundly suppress gastric acid secretion, and thus have become the treatment of choice for gastro-oesophageal reflux disease and peptic ulcer disease. PPIs are considered safe and effective. It is
Vasudevan G. Naidoo
doaj   +1 more source

Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients [PDF]

, 2017
To the Editor: Proton Pump Inhibitors (PPIs) taken for ≥1 year have been linked to increased fragility fracture (FF) risk, prompting the US FDA to issue a related warning.
W Henley (16997595), W Hamilton (19248520), A Ble (21848018), JA Masoli (21848024), J Delgado (7769732), D Melzer (14728009), J Zirk-Sadowski (21848027), WD Strain (14423826)   +7 more
core   +3 more sources

Drug codes for proton pump inhibitors and Parkinson’s disease drugs.

, 2023
Drug codes for proton pump inhibitors and Parkinson’s disease drugs.
Bora Lee (555307), Kwang Jae Lee (5081594), Hye-Kyung Jung (2936187), Eun Jeong Gong (2658457), Young Hoon Youn (3098199), Cheol Min Shin (3160704), Jong Wook Kim (5593796), Ji Taek Hong (8654753)   +7 more
core   +1 more source